These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17613807)

  • 1. Obesity, insulin resistance, and renal function.
    Knight SF; Imig JD
    Microcirculation; 2007; 14(4-5):349-62. PubMed ID: 17613807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
    Cubbon RM; Kahn MB; Wheatcroft SB
    Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue.
    Eringa EC; Bakker W; Smulders YM; Serné EH; Yudkin JS; Stehouwer CD
    Microcirculation; 2007; 14(4-5):389-402. PubMed ID: 17613810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications.
    Sarafidis PA; Ruilope LM
    Am J Nephrol; 2006; 26(3):232-44. PubMed ID: 16733348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.
    Lionetti L; Mollica MP; Lombardi A; Cavaliere G; Gifuni G; Barletta A
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):146-52. PubMed ID: 19171470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular dysfunction in obesity and insulin resistance.
    Frisbee JC
    Microcirculation; 2007; 14(4-5):269-71. PubMed ID: 17613800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance.
    Singer G; Granger DN
    Microcirculation; 2007; 14(4-5):375-87. PubMed ID: 17613809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocyte lesions in patients with obesity-related glomerulopathy.
    Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
    Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and endothelial cell dysfunction: studies in mammalian models.
    Kearney MT; Duncan ER; Kahn M; Wheatcroft SB
    Exp Physiol; 2008 Jan; 93(1):158-63. PubMed ID: 17933859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal consequences of obesity.
    Naumnik B; Myśliwiec M
    Med Sci Monit; 2010 Aug; 16(8):RA163-70. PubMed ID: 20671624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
    Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
    Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Overweight and obesity--risk factors in the development and progression of renal disease].
    Sebeková K; Klassen A; Bahner U; Heidland A
    Vnitr Lek; 2004 Jul; 50(7):544-9. PubMed ID: 15323263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Obesity, inflammation and insulin resistance: which role for adipokines].
    Antuna-Puente B; Feve B; Fellahi S; Bastard JP
    Therapie; 2007; 62(4):285-92. PubMed ID: 17983554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, insulin resistance and kidney disease risk: insights into the relationship.
    Sarafidis PA
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipokines: the missing link between insulin resistance and obesity.
    Antuna-Puente B; Feve B; Fellahi S; Bastard JP
    Diabetes Metab; 2008 Feb; 34(1):2-11. PubMed ID: 18093861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The importance of overweight and obesity for the development and progression of renal diseases].
    Klassen A; Bahner U; Sebekova K; Heidland A
    Dtsch Med Wochenschr; 2004 Mar; 129(11):579-82. PubMed ID: 14997412
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inflammation and insulin resistance: chronic renal disease features].
    Guebre-Egziabher F; Juillard L; Kalbacher E; Bachetta J; Fouque D
    Nephrol Ther; 2010 Feb; 6 Suppl 1():S7-12. PubMed ID: 20172498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energy balance, physical activity, and cancer risk.
    Fair AM; Montgomery K
    Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of obesity in children on kidney].
    Roszkowska-Blaim M
    Przegl Lek; 2006; 63 Suppl 3():25-8. PubMed ID: 16898481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.